Q4 2020 Bayer AG Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to Bayer's investor and analyst conference call on the full year and fourth quarter 2020 results. (Operator Instructions) I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead.
Great. Thank you so much, Haley. Good afternoon, and thanks, everybody, for joining us today. I'd like to welcome all of you for our full year 2020 conference call.
With me on the call today are Werner Baumann, our CEO; and Wolfgang Nickl, our CFO. And as always, the businesses are represented by the responsible Management Board members. So we have Stefan Oelrich for Pharma. We have Liam Condon for Crop Science. And we have Heiko Schipper for Consumer Health.
Werner will begin today's call with an overview of the key developments, performance of the divisions and the strategic outlook, while Wolfgang will then cover the financials for the full year as well as the outlook for 2021 before we open
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |